Cargando…
Clinical significance of the uPA system in gastric cancer with peritoneal metastasis
BACKGROUND: It has been demonstrated that urokinase-type plasminogen activator (uPA) is involved in tumor cell metastasis by degrading the extracellular matrix. However, there is little direct evidence of clinical uPA system expression in peritoneal metastatic tissues of gastric cancer. The objectiv...
Autores principales: | Ding, Youcheng, Zhang, Hui, Zhong, Mingan, Zhou, Zhuqing, Zhuang, Zhixiang, Yin, Hua, Wang, Xujing, Zhu, Zhenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766264/ https://www.ncbi.nlm.nih.gov/pubmed/23985164 http://dx.doi.org/10.1186/2047-783X-18-28 |
Ejemplares similares
-
u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer
por: Ding, Youcheng, et al.
Publicado: (2012) -
TEM8 functions as a receptor for uPA and mediates uPA-stimulated EGFR phosphorylation
por: Zhang, Lian-Cheng, et al.
Publicado: (2018) -
Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry
por: Singer, C.F., et al.
Publicado: (2022) -
The uPA/uPAR system in astrocytic wound healing
por: Yepes, Manuel
Publicado: (2022) -
Construction of a Single Lentiviral Vector Containing Tetracycline-Inducible Alb-uPA for Transduction of uPA Expression in Murine Hepatocytes
por: Bai, Jiasi, et al.
Publicado: (2013)